Skip to main content

Genitourinary Cytopathology (Kidney and Urinary Tract)

  • Chapter
  • First Online:
Cytopathology in Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 160))

Abstract

This chapter focuses on genitourinary tract cytology, specifically fine needle aspiration (FNA) of the renal mass lesions and urinary tract cytology. FNAs of renal masses have been performed for diagnosis or confirmation of advanced neoplasia and metastases, and/or staging of tumors. In the age of multimodality treatment options (surgery, cryoablation, radiofrequency ablation, etc.), there is a role for precise pretreatment characterization of the renal masses by FNA, which would decrease the unnecessary treatment for benign diseases and reduce the treatment-related mortality and morbidity in addition to reducing the patient care costs. To date, urine cytology remains the gold standard for bladder cancer screening. It has been, and still is the test against which all new tests are compared when evaluating potential bladder tumor markers. In the last 20 years, a number of noninvasive tests have been developed to detect urothelial carcinoma. Although some have been able to show a better sensitivity compared to cytology, only a few have been close to reaching the sensitivity seen in cytology. Combining some of the new markers with cytologic evaluation may optimize their performance status.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Katz RL (1997) Kidneys, adrenals and retroperitoneum. In: Bibbo M, Wilbur DC (eds) Comprehensive cytology, 2nd edn. WB Saunders, Philadelphia, pp 781–821

    Google Scholar 

  2. Renshaw AA, Granter SR, Cibas E (1997) Fine-needle aspiration of the adult kidney. Cancer Cytopath 81:71–88

    Article  CAS  Google Scholar 

  3. Volpe A, Kachura JR, Geddie WR, Evans AJ, Gharajeh A, Saravanan A, Jewett M (2007) Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178:379–386

    Article  PubMed  Google Scholar 

  4. Gibbons RP, Bush WH Jr, Burnett LL (1977) Needle tract seeding following aspiration of renal cell carcinoma. J Urol 118:865–867

    PubMed  CAS  Google Scholar 

  5. Kiser GC, Totonchy M, Barry JM (1986) Needle tract seeding after percutaneous aspiration of renal adenocarcinoma. J Urol 136:1292–1293

    PubMed  CAS  Google Scholar 

  6. Shenoy PD, Lakhkar BN, Ghosh MK, Patil UD (1991) Cutaneous seeding of renal carcinoma by Chiba needle aspiration biopsy. Case report. Acta Radiol 32:50

    Article  CAS  Google Scholar 

  7. Wehle MJ, Grabstald H (1986) Contraindications to needle aspiration of a solid renal mass: tumor dissemination by renal needle aspiration. J Urol 136:446

    PubMed  CAS  Google Scholar 

  8. Auvert J, Abbou CC, Lavarenne V (1982) Needle tract seeding following puncture of renal oncocytoma. Prog Clin Biol Res 100:597

    PubMed  CAS  Google Scholar 

  9. Abe M, Saitoh M (1992) Selective renal tumour biopsy under ultrasonic guidance. Br J Urol 70:7

    Article  PubMed  CAS  Google Scholar 

  10. Wunderlich H, Hindermann W, Al Mustafa AM, Reichelt O, Junker K Schubert J (2005) The accuracy of 250 fine needle biopsies of renal tumors. J Urol 174:44

    Google Scholar 

  11. Smith EH (1991) Complications of percutaneous abdominal fine-needle biopsy. Review Radiol. 178:253–258

    CAS  Google Scholar 

  12. Brierly RD, Thomas PJ, Harrison NW, Fletcher MS, Nawrocki JD, Ashton-Key M (2000) Evaluation of fine-needle aspiration cytology for renal masses. BJU Int 85:14–18

    Article  PubMed  CAS  Google Scholar 

  13. Todd LD, Truong TD, Dhurandhar B, Ramzy I (1999) Fine-needle aspiration of renal masses in adults; analysis of results and diagnostic problems in 108 cases. Diagn Cytopathol 20:339–349

    Article  PubMed  Google Scholar 

  14. Campbell SC, Novick AC, Herts B, Fischler DF, Meyer J, Levin HS, Chen RN (1997) Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology 50:25–29

    Article  PubMed  CAS  Google Scholar 

  15. Haubek A, Lundorf E, Lauridsen KN (1991) Diagnostic strategy in renal mass lesions. Scand J Urol Nephrol Suppl 137:35–39

    PubMed  CAS  Google Scholar 

  16. Orell SR, Langlois SL, Marshall VR (1985) Fine needle aspiration cytology in the diagnosis of solid renal and adrenal masses. Scand J Urol Nephrol 19:211–216

    Article  PubMed  CAS  Google Scholar 

  17. Murphy WM, Zambroni BR, Emerson LD (1985) Aspiration biopsy of the kidney. Cancer 56:200–205

    Article  PubMed  CAS  Google Scholar 

  18. Juul N, Torp-Pedersen S, Gronvall S, Holm HH, Koch F, Larsen S (1985) Ultrasonically guided fine needle aspiration biopsy of renal masses. J Urol 133:579–581

    PubMed  CAS  Google Scholar 

  19. Lang EK (1987) Renal cyst puncture studies. Urol Clin North Am 14:91–102

    PubMed  CAS  Google Scholar 

  20. de Kernion JB, Belldegrun A (1992) Renal tumors. In: Campbell MF, Retik AB, Vaughan ED, Walsh PC (eds) Campbell’s Urology, 2nd edn. WB Saunders, Philadelphia, pp 1055–1067

    Google Scholar 

  21. Bosniak MA (1991) Difficulties in classifying cystic lesions of the kidney. Urol Radiol 13:91–93

    Article  PubMed  CAS  Google Scholar 

  22. Truong LD, Krishnan B, Barrios R et al (1995) Renal neoplasms in acquired cystic disease of the kidney. Am J Kidney Dis 26:1–12

    Article  PubMed  CAS  Google Scholar 

  23. Emmet JL, Levine SR, Woolner LB (1963) Co-existence of renal cyst and tumor: incidence of 1007 cases. Br J Urol 35:403–410

    Article  Google Scholar 

  24. Khorsand D (1965) Carcinoma within solitary renal cysts. J Urol 93:440–444

    PubMed  CAS  Google Scholar 

  25. Hughson M, Hennigar G, McManus J (1980) Atypical cysts, acquired renal cystic disease and renal cell tumors in end stage dialysis kidneys. Lab Invest 42:475–480

    PubMed  CAS  Google Scholar 

  26. Nguyen GK, Percutaneous FNA (1987) biopsy cytology of the kidney and adrenal. Pathol Annual 22:163–191

    Google Scholar 

  27. Silverman JF, Gurley AM, Harris JP et al (1991) Fine needle aspiration cytology of renal infarcts. Cytomorphologic findings and potential diagnostic pitfalls in two cases. Acta Cytol 35:736–741

    PubMed  CAS  Google Scholar 

  28. Kruger S, Sotlar K, Kausch I, Horny HP (2005) Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma. Oncology 68:269–275

    Article  PubMed  Google Scholar 

  29. Mazal PR, Exner M, Haitel A, Krieger S, Thomson RB, Aronson PS, Susani M (2005) Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum Pathol 36:22–28

    Article  PubMed  CAS  Google Scholar 

  30. Garcia E, Li M (2006) Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am J Clin Pathol 125:392–398

    PubMed  Google Scholar 

  31. Alroy J, Ucci AA, Azabdoaftari G, Banner BF, Cheville JC (2005) Expression of CD3 antigens in renal tubule epithelium and renal oncocytomas. Pathol Res Pract 201:803–808

    Article  PubMed  CAS  Google Scholar 

  32. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V (2005) Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch 447:938–946

    Article  PubMed  CAS  Google Scholar 

  33. Assad L, Resetkova E, Oliveira VL, Sun W, Stewart JM, Katz RL, Caraway NP (2005) Cytologic features of renal medullary carcinoma. Cancer 1051:28–34

    Google Scholar 

  34. Santamaria M, Jauregui I, Urtasun F, Bertol A (1995) Fine needle aspiration biopsy in urothelial carcinoma of renal pelvis. Acta Cytol 39:443–448

    PubMed  CAS  Google Scholar 

  35. Gattuso P, Ramzy I, Truong LD (1999) Utilization of fine-needle aspiration in the diagnosis of metastatic tumors to the kidney. Diagn Cytopathol 21:35–38

    Article  PubMed  CAS  Google Scholar 

  36. Lambl W Uber Harnblasenkrebs. Einbeitag zur mikroskopischen Diagnostic am Krakenbette. Prager Vierteljahreshift f. Heilkunde. 1865;49:1–15

    Google Scholar 

  37. Sanders WR (1864) Cancer of the bladder. Fragments forming urethral plugs discharged in urine. Concentric colloid bodies. Edinb Med J 10:273–275

    Google Scholar 

  38. Papanicolaou GN, Marshall VF (1945) Urine sediment smears: a diagnostic procedure in cancers of urinary tract. Science 101:519–521

    Article  PubMed  CAS  Google Scholar 

  39. Koss L, Melamed M (2005) In: Koss’ diagnostic cytology and its histopathologic bases, Koss L, Melamed M eds 5th ed. Philadelphia, PA: Lipincott Williams & Wilkins; 2005:38–846

    Google Scholar 

  40. Brown FM (2000) Urine Cytology Is it still the gold standard for screening? Urol Clin North Am 27:25–37

    Article  PubMed  CAS  Google Scholar 

  41. Morse N, Melamed MR (1974) Differential counts of cell populations in urinary sediment from patients with primary epidermoid carcinoma of bladder. Acta Cytol 18:312–315

    PubMed  CAS  Google Scholar 

  42. Murphy WM, Crabtree WN, Jukkola WN, Soloway MS (1981) The diagnostic value of urine versus bladder washing in patients with bladder cancer. J Urol 126:320–322

    PubMed  CAS  Google Scholar 

  43. Wright RG, Halford JA (2001) Evaluation of thin-layer methods in urine cytology. Cytopathology 12:306–313

    Article  PubMed  CAS  Google Scholar 

  44. Elsheikh TM, Kirkpatrick JL, Wu HH (2006) Comparison of ThinPrep and Cytospin preparations in the evaluation of exfoliative cytology specimens. Cancer 108:144–149

    Article  PubMed  Google Scholar 

  45. Hwang EC, Park SH, Jung SI (2007) etal. Usefulness of liquid-based preparation in urine cytology. Int J Urol 14:626–629

    Article  PubMed  Google Scholar 

  46. Jemal A, Siegal R, Ward E. et al (2008) Cancer statistics, 2008 CA. Cancer J Clin 58:71–96

    Google Scholar 

  47. Tavora F, Fjardo DA et al (2009) Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. AJSP 33:1540–1546

    Google Scholar 

  48. Gittes RF (1984) Retrograde brushing and nephroscopy in the diagnosis of upper tract urothelial cancer. Urol Clin North Am 11:617–622

    PubMed  CAS  Google Scholar 

  49. Havens MA, Cabay RJ, Mehrotra S, Kapur U, Wojcik EM, Barkan GA (2009) Upper genitourinary tract cytology: more sensitive than surgical biopsy? Cancer Cytopath 117:371

    Google Scholar 

  50. Coleman DV (1975) The cytodiagnosis of human polyoma virus infection. Acta Cytol 19:93–96

    PubMed  CAS  Google Scholar 

  51. Kahan AV, Coleman DV, Koss LG (1980) Activation of human polyoma virus infection. Detection by cytologic techniques. Am J Clin Pathol 74:326–332

    PubMed  CAS  Google Scholar 

  52. Koss LG, Sherman AB, Eppich E (1984) Image analysis and DNA content of urothelial cells infected with human polyoma virus. Anal Quant Cytol 6:89–94

    PubMed  CAS  Google Scholar 

  53. Koss LG (1995) Cytologic manifestation of benign disorders affecting cells of the lower urinary tract. In: Koss LG (ed) Diagnostic cytology of the urinary tract: with histopathologic and clinical correlation, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 52–55

    Google Scholar 

  54. Wojcik EM, Miller MC, Wright BC, Veltri RW, O’Dowd GJ (1997) Comparative analysis of DNA content in Polyoma Virus infected urothelial cells, urothelial dysplasia and transitional cell carcinoma. Anal Quant Cytol Histol 19:430–436

    PubMed  CAS  Google Scholar 

  55. Highman W, Wilson E (1982) Urine cytology in patients with calculi. J Clin Pathol 35:350–356

    Article  PubMed  CAS  Google Scholar 

  56. Rubben H, Hering F, Dahm HH, Lutzeyer W (1982) Value of exfoliative urinary cytology for differentiation between uric acid stone and tumor of upper urinary tract. Urology 22:571–573

    Article  Google Scholar 

  57. Betz SA, See WA, Cohen MB (1993) Granulomatous inflammation in bladder wash specimens after intravesical Bacillus Calmette-Guerin therapy for transitional cell carcinoma of the bladder. Am J Clin Pathol 99:244–248

    PubMed  CAS  Google Scholar 

  58. Forni AM, Koss LG, Geller W (1964) Cytological study of the effect of cyclophosphamide in man. Cancer 17:1348–1355

    Article  PubMed  CAS  Google Scholar 

  59. Murphy WM, Soloway MS, Finebaum PJ (1981) Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 126:461–464

    Google Scholar 

  60. Solomon D, Nayar R, Davey D, Wilbur D, Kurman R (eds.) (2004) In the bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes, 2nd edn. Springer, New York, pp 1–188

    Google Scholar 

  61. Renshaw AA (2000) Subclassifying atypical urinary cytology specimens. Cancer 90:222–229

    Article  PubMed  CAS  Google Scholar 

  62. Kapur U, Venkataraman G, Wojcik EM (2008) Diagnostic significance of ‘atypia’ in instrumented versus voided urine specimens. Cancer 114:270–274

    Article  PubMed  Google Scholar 

  63. Raab SS, Grzybicki DM, Vrbin CM, Geisenger KR (2007) Urine cytology discrepancies. Am J Clin Pathol 127:946–953

    Article  PubMed  Google Scholar 

  64. Bhatia A, Dey P, Kakkar N, Srinivasan R, Nijhawan R (2006) Malignant atypical cell in urine cytology: a diagnostic dilemma. Cyto journal 3:28–33

    PubMed  Google Scholar 

  65. Deshpande V, McKee GT (2005) Analysis of atypical urine cytology in a tertiary care center. Cancer 105:468–475

    Article  PubMed  Google Scholar 

  66. Palmer D, Lallu S, Matheson P, Bethwaite P, Tompson K (2007) Karyomegalic interstitial nephritis: a pitfall in urine cytology. Diagn Cytopathol 35:179–182

    Article  PubMed  Google Scholar 

  67. Epstein JI, Amin MB, Reuter VR, Mostofi FK et al. (1998) for the bladder consensus conference committee. The World Health Organization/International Society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22:1435–1448

    Google Scholar 

  68. Badelment RA, Kimmoel M, Gay H, Cibas ES, Whitmore WF Jr, Herr HW, Fair WR, Melamed MR (1987) The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer 59:2078–2085

    Article  Google Scholar 

  69. Danque PO, Chen HB, Patil J, Jagirdar J, Orsatti G, Paronetto F (1993) Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol 6:270–275

    PubMed  CAS  Google Scholar 

  70. Wojcik EM, Bassler TJ, Orozco R (1999) DNA ploidy of seminal vesicle cells. A potential diagnostic pitfall in urine cytology. Analyt Quant Cytol Histol 21:29–34

    Google Scholar 

  71. Bakhos R, Shankey TV, Fisher S, Flanigan RC, Wojcik EM (2000) Comparative analysis of DNA flow cytometry and cytology of urine barbotages—review of discordant cases. Diagn Cytopathol. 22: 65–69

    Google Scholar 

  72. Wojcik EM, Brownlie RJ, Bassler TJ, Miller MC (2000) Superficial urothelial cells (umbrella cells)—a potential cause of abnormal DNA ploidy results in urine specimens. Analyt Quant Cytol Histol 22:411–415

    CAS  Google Scholar 

  73. Hajdinjak T (2008) UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol Oncol 26:646–651

    Article  PubMed  CAS  Google Scholar 

  74. van Rhijn BW, van der Poel HG, van der Kwast TH (2005) Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47:736–748

    Article  PubMed  Google Scholar 

  75. Fradet Y, Lockhart C (1997) The immunocyt trialists. Performance characteristics of a new monoclonal antibody test for bladder cancer. ImmunocytT M. Can J Urol 4:400–405

    PubMed  Google Scholar 

  76. Tetu B (2009) Diagnosis of urothelial carcinoma. Urine Modern Pathol. 22:S53–S59

    Google Scholar 

  77. Melissourgos ND, Kastrinakis NG, Skolarikos A et al (2005) Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder. Urology 66:536–541

    Article  PubMed  Google Scholar 

  78. Lokeshwar VB, Soloway MS (2001) Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 165:1067–1077

    Article  PubMed  CAS  Google Scholar 

  79. Grossman HB, Soloway M, Messing E et al (2006) Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA 295:299–305

    Article  PubMed  CAS  Google Scholar 

  80. Serretta V, Pomara G, Rizzo I et al (2000) Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder. Eur Urol 38:419–425

    Article  PubMed  CAS  Google Scholar 

  81. Giannopoulos A, Manousakas T, Mitropoulos D et al (2000) Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors. Urology 55:871–875

    Article  PubMed  CAS  Google Scholar 

  82. Shariat SF, Marberger MJ, Lotan Y et al (2006) Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. J Urol 176:919–926

    Article  PubMed  CAS  Google Scholar 

  83. Lokeshwar VB, Habuchi T, Grossman HB et al (2005) Bladder tumor markers beyond cytology: International consensus panel on bladder tumor markers. Urology 66:35–63

    Article  PubMed  Google Scholar 

  84. Hautmann S, Toma M, Lorenzo GMF et al (2004) Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. Eur Urol 46:466–471

    Google Scholar 

  85. Soloway MS (2008) Possible malignancy after cytology analysis in a 45-year old man. Curr Urol Rep 9:182–184

    Article  PubMed  Google Scholar 

  86. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:2217

    Article  PubMed  Google Scholar 

  87. Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E et al (2003) Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 170:64

    Article  PubMed  Google Scholar 

  88. Link RE, Bhayani SB, Allaf ME, Varkarakis I, Inagaki T, Rogers C (2005) Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol 173:1690

    Article  PubMed  Google Scholar 

  89. Kroft SH, Oyasu R (1994) Urinary bladder cancer: mechanisms of development and progression. Lab Invest 71:158–174

    PubMed  CAS  Google Scholar 

  90. Soloway MS (1999) Editorial: Do we have a prostate specific antigen for bladder cancer? J Urol 161:447–448

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Güliz A. Barkan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Barkan, G.A., Wojcik, E.M. (2014). Genitourinary Cytopathology (Kidney and Urinary Tract). In: Nayar, R. (eds) Cytopathology in Oncology. Cancer Treatment and Research, vol 160. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38850-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38850-7_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38849-1

  • Online ISBN: 978-3-642-38850-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics